Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia.
Reinders-Messelink HA, Van Weerden TW, Fock JM, Gidding CE, Vingerhoets HM, Schoemaker MM, Göeken LN, Bökkerink JP, Kamps WA. Reinders-Messelink HA, et al. Among authors: kamps wa. Eur J Paediatr Neurol. 2000;4(5):225-33. doi: 10.1053/ejpn.1999.0310. Eur J Paediatr Neurol. 2000. PMID: 11030069 Clinical Trial.
Vincristine revisited.
Gidding CE, Kellie SJ, Kamps WA, de Graaf SS. Gidding CE, et al. Among authors: kamps wa. Crit Rev Oncol Hematol. 1999 Feb;29(3):267-87. doi: 10.1016/s1040-8428(98)00023-7. Crit Rev Oncol Hematol. 1999. PMID: 10226730 Review. No abstract available.
Vincristine pharmacokinetics after repetitive dosing in children.
Gidding CE, Meeuwsen-de Boer GJ, Koopmans P, Uges DR, Kamps WA, de Graaf SS. Gidding CE, et al. Among authors: kamps wa. Cancer Chemother Pharmacol. 1999;44(3):203-9. doi: 10.1007/s002800050968. Cancer Chemother Pharmacol. 1999. PMID: 10453721 Clinical Trial.
The influence of recombinant human insulin-like growth factor-I (rhIGF-I) on cell growth and cytotoxicity of drugs in childhood rhabdomyosarcoma cell lines and xenograft models.
Gidding CE, Germain GS, Dilling MB, Meeuwsen-de Boer TG, Ashmun RA, de Graaf SS, Veverka KA, Kamps WA, Houghton PJ. Gidding CE, et al. Among authors: kamps wa. Cancer Chemother Pharmacol. 2000;45(1):21-30. doi: 10.1007/PL00006738. Cancer Chemother Pharmacol. 2000. PMID: 10647497
Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991).
Kamps WA, Bökkerink JP, Hählen K, Hermans J, Riehm H, Gadner H, Schrappe M, Slater R, van den Berg-de Ruiter E, Smets LA, de Vaan GA, Weening RS, van Weerden JF, van Wering ER, den der Does-van den Berg A. Kamps WA, et al. Blood. 1999 Aug 15;94(4):1226-36. Blood. 1999. PMID: 10438710 Free article. Clinical Trial.
BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996).
Kamps WA, Bökkerink JP, Hakvoort-Cammel FG, Veerman AJ, Weening RS, van Wering ER, van Weerden JF, Hermans J, Slater R, van den Berg E, Kroes WG, van der Does-van den Berg A. Kamps WA, et al. Leukemia. 2002 Jun;16(6):1099-111. doi: 10.1038/sj.leu.2402489. Leukemia. 2002. PMID: 12040440 Clinical Trial.
224 results